3 Great Shares For A Beginners’ Portfolio: GlaxoSmithKline plc, Schroders plc & Latchways plc

GlaxoSmithKline plc (LON:GSK), Schroders plc (LON:SDR) and Latchways plc (LON:LTC) are three shares that could help transform your wealth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

gskMulti-billionaire Warren Buffett, probably the world’s most famous and successful investor, follows a strategy of buying great businesses with a view to holding his shares ‘forever’.

What’s good enough for octogenarian Buffett should be good enough for an investor just starting out on the road to long-term wealth accumulation.

Today, I’m going to tell you why I think GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US), Schroders (LSE: SDR) and Latchways (LSE: LTC) are worth consideration for a beginner’s portfolio.

GlaxoSmithKline

Pharmaceuticals giant GlaxoSmithKline has a market capitalisation of £70bn, and is the fourth-largest company in the FTSE 100. The company is a ‘core’ holding for many investors.

Size, prodigious cash generation and the ‘non-cyclical’ nature of the pharma industry make Glaxo a relatively steady share through all economic conditions. The company has a great dividend history, and the prospective dividend yield is currently 5.7% at a share price of 1,434p. Reinvest the dividends to buy more shares year after year and the value of your investment should snowball over the long term.

Schroders 

Asset manager Schroders (founded in 1804) is also in the FTSE 100. With a market capitalisation of £6.5bn, Schroders may not be in the ‘megacap’ league of Glaxo, but I believe it has attractions for long-term investors.

The nature of Schroders’ business means its shares tend to exaggerate the returns of the wider market. Shareholders have to steel themselves when markets wobble, but because markets rise over the long term (multi-decades) the reward should be outsize returns if Schroders continues to do what it’s done successfully for over 200 years.

Unusually, the company has two classes of share: voting shares (ticker SDR) and non-voting shares (LSE: SDRC). Small private investors have little to gain from holding the voting shares. The non-voting shares are cheaper (currently 1,851p versus 2,435p for the voting shares), and provide a bigger dividend yield: 3.7% versus 2.8%.

Latchways

Smaller companies are considered inherently more risky than big companies — but they also have potential to grow faster. Furthermore, some smaller businesses have the kind of qualities Buffett looks for, and even a beginner may want to consider including a smattering of such shares in a portfolio.

Latchways, which has a market capitalisation of £109m, is the global leader in fall protection equipment for people working at height. Safety is not something employers can afford to skimp on. Latchways’ reputation as the number one — built over 30 years — and increasing safety regulation around the world, give the company plenty of scope to continue growing strongly.

Recent cyclical weakness is some of Latchways’ markets, notably commercial construction in parts of Europe, means investors today can buy the shares at a lower price (965p) than would otherwise have been the case. It also means that the prospective dividend yield (4.4%) is higher than usual.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. The Motley Fool UK owns shares of Latchways. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Trader on video call from his home office
Investing Articles

Down 19%! Here’s why Barclays shares look a serious bargain to me right now

Barclays shares have slumped recently, but a big gap between price and fair value has opened, offering nimble long-term investors…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

Why Meta Platforms shares fell 12.5% in March

Historically, investors have done well by buying Meta Platforms shares when the price has fallen. But is the latest legal…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

£20,000 invested in BAE Systems shares 4 years ago is now worth…

BAE Systems' shares have soared since 2022, yet rising NATO budgets are just starting to feed through, so the real…

Read more »

This way, That way, The other way - pointing in different directions
Investing For Beginners

Aviva shares fell 12% in March! Here’s my outlook from here

Jon Smith explains why Aviva shares underperformed last month, but paints an upbeat picture for the stock when looking further…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

A 6.3% forecast yield! 1 bargain-basement FTSE passive income gem to buy today?  

This FTSE 100 passive income star has delivered consistently high dividends, with analysts forecasting more to come, and it looks…

Read more »

British coins and bank notes scattered on a surface
Investing Articles

£100 invested in a Stocks and Shares ISA today could be worth…

A Stocks and Shares ISA is a proven way of building wealth. But how much could a smaller stake of…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

April opportunities: 2 heavily-discounted stocks to consider buying

Are under-the-radar growth stocks the best place to look for potential stocks to buy as investors look for certainty in…

Read more »

Workers at Whiting refinery, US
Investing Articles

Why the BP share price *finally* surged 24.5% in March

Long-term owners of BP stock have had a frustrating few years, but is the share price rising 24.5% in March…

Read more »